Folgen
Otilia Menyhart
Otilia Menyhart
Semmelweis Egyetem
Bestätigte E-Mail-Adresse bei cornell.edu
Titel
Zitiert von
Zitiert von
Jahr
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Á Nagy, A Lánczky, O Menyhárt, B Győrffy
Scientific reports 8 (1), 9227, 2018
12462018
Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
O Menyhárt, Á Nagy, B Győrffy
Royal Society open science 5 (12), 181006, 2018
3652018
Guidelines for the selection of functional assays to evaluate the hallmarks of cancer
O Menyhárt, H Harami-Papp, S Sukumar, R Schäfer, L Magnani, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1866 (2), 300-319, 2016
1632016
Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis
O Menyhárt, B Győrffy
Computational and structural biotechnology journal 19, 949-960, 2021
1592021
MultipleTesting. com: A tool for life science researchers for multiple hypothesis testing correction
O Menyhart, B Weltz, B Győrffy
PloS one 16 (6), e0245824, 2021
832021
HOXC10 expression supports the development of chemotherapy resistance by fine tuning DNA repair in breast cancer cells
H Sadik, P Korangath, NK Nguyen, B Gyorffy, R Kumar, M Hedayati, ...
Cancer research 76 (15), 4443-4456, 2016
732016
Author Correction: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Á Nagy, A Lánczky, O Menyhárt, B Győrffy
Scientific reports 8, 2018
692018
Juvenile zebra finches learn the underlying structural regularities of their fathers’ song
O Menyhart, O Kolodny, MH Goldstein, TJ DeVoogd, S Edelman
Frontiers in Psychology 6, 571, 2015
652015
Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches
O Menyhárt, B Győrffy
Cancer and Metastasis Reviews 39, 211-233, 2020
642020
Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas
O Menyhárt, F Giangaspero, B Győrffy
Journal of Hematology & Oncology 12, 1-17, 2019
612019
A comprehensive outline of trastuzumab resistance biomarkers in HER2 overexpressing breast cancer
O Menyhart, L Santarpia, B Gyorffy
Current Cancer Drug Targets 15 (8), 665-683, 2015
552015
Demographic shift disproportionately increases cancer burden in an aging nation: current and expected incidence and mortality in Hungary up to 2030
O Menyhárt, JT Fekete, B Győrffy
Clinical Epidemiology, 1093-1108, 2018
432018
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 2018; 8: 9227
Á Nagy, A Lánczky, O Menyhárt, B Győrffy
Journal of Gastrointestinal Oncology. All rights reserved. J Gastrointest …, 2020
342020
Mutations defining patient cohorts with elevated PD-L1 expression in gastric cancer
O Menyhárt, LS Pongor, B Győrffy
Frontiers in Pharmacology 9, 430580, 2019
342019
DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer
O Menyhart, J Budczies, G Munkácsy, FJ Esteva, A Szabó, TP Miquel, ...
Oncotarget 8 (44), 77207, 2017
332017
Principles of tumorigenesis and emerging molecular drivers of SHH‐activated medulloblastomas
O Menyhárt, B Győrffy
Annals of Clinical and Translational Neurology 6 (5), 990-1005, 2019
282019
Contingent parental responses are naturally associated with zebra finch song learning
S Carouso-Peck, O Menyhart, TJ DeVoogd, MH Goldstein
Animal Behaviour 165, 123-132, 2020
252020
Uncovering potential therapeutic targets in colorectal cancer by deciphering mutational status and expression of druggable oncogenes
O Menyhart, T Kakisaka, LS Pongor, H Uetake, A Goel, B Győrffy
Cancers 11 (7), 983, 2019
232019
Gene expression-based biomarkers designating glioblastomas resistant to multiple treatment strategies
O Menyhárt, JT Fekete, B Győrffy
Carcinogenesis 42 (6), 804-813, 2021
222021
Gene expression indicates altered immune modulation and signaling pathway activation in ovarian cancer patients resistant to topotecan
O Menyhárt, JT Fekete, B Győrffy
International Journal of Molecular Sciences 20 (11), 2750, 2019
202019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20